PrecisionLife is attending the international BIO Europe 2021 gathering alongside global biopharma and investment leaders to build partnerships that facilitate innovation and medical breakthroughs with our unique combinatorial analytics driving precision medicine for common disease.
At BIO Europe 2021 PrecisionLife is seeking to connect with biotechnology and pharmaceutical companies with interest in collaborating on novel targets within a range of complex chronic disorders, including indications where we have already identified potential novel therapeutic targets and an ability to stratify patient populations: Alzheimer’s Disease, Parkinson’s Disease, ALS, Schizophrenia, Womens Health, asthma and diabetes.